Raghvendra M. Srivastava

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial”.

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

Nature Cancer(2020)10.1038/s43018-020-00139-8

N/A

0.806DataRank · unranked

214 citations

Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov +23 more

Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis

Immunity(2023)10.1016/j.immuni.2023.10.010

N/A

0.609DataRank · unranked

57 citations

Wei Shi, Liangliang Ji, Erik Ladewig, Xian Zhang, Raghvendra M. Srivastava +16 more

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab

Nature Medicine(2024)10.1038/s41591-024-03240-y

N/A

0.546DataRank · unranked

37 citations

Nadeem Riaz, Prerana Bangalore Parthasarathy, Vladimir Makarov, Sviatoslav M. Kendall, Seong‐Keun Yoo +16 more

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

Nature Genetics(2022)10.1038/s41588-022-01108-w

N/A

0DataRank · unranked

79 citations

Nadeem Riaz, Robert Samstein, Mark Lee, Vladimir Makarov, Cristina Valero +29 more

Diverse Neoantigens and the Development of Cancer Therapies

Seminars in Radiation Oncology(2020)10.1016/j.semradonc.2019.12.001

N/A

0DataRank · unranked

15 citations

Tanaya A. Purohit, Timothy A. Chan, Raghvendra M. Srivastava

Editorial: Lymphocyte functional crosstalk and regulation, volume II

Frontiers in Immunology(2023)10.3389/fimmu.2023.1214843

N/A

0DataRank · unranked

0 citations

Menaka C. Thounaojam, Francesco M. Marincola, Anil Shanker, Raghvendra M. Srivastava

Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae143

N/A

0DataRank · unranked

17 citations

Kanika G. Nair, Shimoli V. Barot, Xiang Shao, Suneel D. Kamath, Marilena Melas +18 more

IRF8 Governs Tumor-Associated Macrophage Control of T Cell Exhaustion

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.12.989731

N/A

0DataRank · unranked

4 citations

Fengshen Kuo, Ming Liu, Kristelle J. Capistrano, Mytrang Do, Ruth A. Franklin +15 more

The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs

Nature Communications(2025)10.1038/s41467-025-64983-x

N/A

0DataRank · unranked

4 citations

Pooneh Koochaki, Sayed Matar, Fatme Ghandour, Marc Machaalani, Eddy Saad +22 more

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.03.007

N/A

0DataRank · unranked

444 citations

Renzo G. DiNatale, Fengshen Kuo, Raghvendra M. Srivastava, Lynda Vuong, Diego Chowell +28 more